We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 549 results
  1. Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia

    Acetylcholine (ACh) signaling is critical for central nervous function and is known to be abnormal in schizophrenia (SZ), a chronic neuropsychiatric...
    Chapter 2022
  2. Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study

    Objectives

    Using multiple drugs with anticholinergic properties is common and might lead to cumulative anticholinergic toxicity and increased risk of...

    Adriana Nancy Medeiros dos Santos, Guilherme Amorim Avilla Gimenez Junior, ... Claudia Kimie Suemoto in European Journal of Clinical Pharmacology
    Article 28 June 2022
  3. A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales

    Background

    Anticholinergic burden potentially increases the risk of fracture. Although there are various anticholinergic burden scales, little is...

    Yukari Ogawa, Toshinori Hirai, Kiyoshi Mihara in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 01 September 2021
  4. Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study

    Purpose

    Drug intake might be a modifiable factor for the individual fall-risk of older adults, and anticholinergic properties of drugs need to be...

    Katja S. Just, Karen A. Schultze, ... Julia C. Stingl in European Journal of Clinical Pharmacology
    Article Open access 29 June 2023
  5. Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review

    Purpose

    The aim of this work was to investigate the association between anticholinergic burden or anticholinergic drug use and xerostomia and/or...

    E. Prado-Mel, P. Ciudad-Gutiérrez, ... A. M. Villalba-Moreno in BMC Pharmacology and Toxicology
    Article Open access 21 December 2022
  6. Comparative associations between anticholinergic burden and emergency department visits for anticholinergic adverse events in older Korean adults: a nested case-control study using national claims data for validation of a novel country-specific scale

    Background

    Considering the limited generalizability of previous anticholinergic burden scales, the Korean Anticholinergic Burden Scale (KABS) as a...

    Sunghee Hwang, Jee Eun Chung, ... Ju-Yeun Lee in BMC Pharmacology and Toxicology
    Article Open access 07 January 2021
  7. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review

    Purpose

    Older people are at risk of anticholinergic side effects due to changes affecting drug elimination and higher sensitivity to drug’s side...

    Angela Lisibach, Valérie Benelli, ... Monika Lutters in European Journal of Clinical Pharmacology
    Article Open access 03 October 2020
  8. Anticholinergic load and delirium in end-of-life patients

    Background

    Delirium is a neuropsychiatric syndrome associated with negative outcomes, including worsening of cognitive and functional status and an...

    Luca Pasina, Barbara Rizzi, ... Angela Recchia in European Journal of Clinical Pharmacology
    Article 17 March 2021
  9. Association between anticholinergic drug burden and mortality in older people: a systematic review

    Purpose

    The purpose of the study is to conduct a systematic review of studies examining the association between anticholinergic burden and mortality...

    Sheraz Ali, Gregory M. Peterson, ... Mohammed S. Salahudeen in European Journal of Clinical Pharmacology
    Article 12 December 2019
  10. Patterns of inappropriate prescribing and clinical characteristics in patients at admission to an acute care of the elderly unit

    Purpose

    Inappropriate prescribing (IP) is common among the elderly and is associated with adverse health outcomes. The role of different patterns of...

    Mónica Zuleta, Antonio San-José, ... Carmen Pérez-Bocanegra in European Journal of Clinical Pharmacology
    Article 24 January 2024
  11. The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV

    Benzodiazepine use is linked to neurocognitive impairment (NCI) in the general population and people with HIV (PWH); however, this relationship may...

    Erin E. Sundermann, Rowan Saloner, ... María J. Marquine in Journal of NeuroVirology
    Article Open access 07 April 2022
  12. Potentially inappropriate medication use and mortality in patients with cognitive impairment

    Purpose

    Potentially inappropriate medications (PIMs) are associated with falls, hospitalization, and cognitive decline. Few studies have investigated...

    Emily Buckley, Agnes Jonsson, ... John J. McCabe in European Journal of Clinical Pharmacology
    Article 03 November 2022
  13. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review

    Purpose

    With increasing age, adults are often exposed to anticholinergic drugs and are prone to potential adverse drug reaction, among which cognitive...

    Laurine Andre, Adeline Gallini, ... Virginie Gardette in European Journal of Clinical Pharmacology
    Article 29 August 2019
  14. Implementation of clinical medication review in a geriatric ward to reduce potentially inappropriate prescriptions among older adults

    Purpose

    The impact of several pharmaceutical interventions to reduce the use of potentially inappropriate medications (PIMs) and potentially omitted...

    Alexandre Meurant, Pascale Lescure, ... Jean-Pierre Jourdan in European Journal of Clinical Pharmacology
    Article 19 August 2023
  15. Pharmacoepidemiology Research Delivering Evidence About Drug Safety in Dementia

    Dementia is one of the main causes of dependency and disability in older adults worldwide. Drug safety is important to define in those living with...
    Living reference work entry 2022
  16. Reliability and validity of the Swedish indicator ‘Drugs that should be avoided in older people’—an appraisal of a set of potentially inappropriate medications

    Purpose

    To analyse the reliability and validity of the Swedish indicator ‘Drugs that should be avoided in older people’.

    Methods

    From a previous study...

    Naldy Parodi López, Staffan A. Svensson, ... Susanna M. Wallerstedt in European Journal of Clinical Pharmacology
    Article Open access 14 May 2024
  17. Utilization of Drug Decision Support Strategies Including Drug Characteristics to Reduce the Risk of Iatrogenesis in Advanced Age

    Purpose of Review

    The goal of this review is to examine currently available risk drug decision support strategies including medication...

    Savanna San Filippo, Marshall Yuan, ... Savan Patel in Current Pharmacology Reports
    Article 09 January 2023
  18. Antidepressant deprescribing: State of the art and recommendations—A literature overview

    Introduction

    In recent years, the consumption of antidepressants has arisen. However, deprescribing antidepressant therapy is very complicated. The...

    Alessia Romagnoli, Andrea Zovi, ... Ruggero Lasala in European Journal of Clinical Pharmacology
    Article 08 January 2024
  19. miR-9-5p is Downregulated in Serum Extracellular Vesicles of Patients Treated with Biperiden After Traumatic Brain Injury

    Traumatic brain injury (TBI) is a prevalent and debilitating condition, which often leads to the development of post-traumatic epilepsy (PTE), a...

    Beatriz Enguidanos Villena-Rueda, Gustavo Satoru Kajitani, ... Sintia Iole Belangero in Molecular Neurobiology
    Article 26 April 2024
  20. Clinical Treatment Available for Schizophrenia

    Schizophrenia is a chronic illness which leads to poor quality of life. Disease course and prognosis depend upon the management of schizophrenia. For...
    Chapter 2023
Did you find what you were looking for? Share feedback.